These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21085063)

  • 1. The role of direct presentation by donor dendritic cells in rejection of minor histocompatibility antigen-mismatched skin and hematopoietic cell grafts.
    Fernandes E; Goold HD; Kissenpfennig A; Malissen B; Dyson J; Bennett CL
    Transplantation; 2011 Jan; 91(2):154-60. PubMed ID: 21085063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Langerhans cells are not required for efficient skin graft rejection.
    Obhrai JS; Oberbarnscheidt M; Zhang N; Mueller DL; Shlomchik WD; Lakkis FG; Shlomchik MJ; Kaplan DH
    J Invest Dermatol; 2008 Aug; 128(8):1950-5. PubMed ID: 18337832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A continuous infusion of a minor histocompatibility antigen-immunodominant peptide induces a delay of male skin graft rejection.
    Sireci G; Barera A; Macaluso P; Di Sano C; Bonanno CT; Pio La Manna M; Di Liberto D; Dieli F; Salerno A
    Immunobiology; 2009; 214(8):703-11. PubMed ID: 19249121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen.
    Valujskikh A; Matesic D; Heeger PS
    Transplantation; 1999 Oct; 68(7):1029-36. PubMed ID: 10532546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusions.
    Eto M; Hackstein H; Kaneko K; Nomoto K; Thomson AW
    J Immunol; 2002 Sep; 169(5):2390-6. PubMed ID: 12193706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells.
    GeurtsvanKessel CH; Willart MA; van Rijt LS; Muskens F; Kool M; Baas C; Thielemans K; Bennett C; Clausen BE; Hoogsteden HC; Osterhaus AD; Rimmelzwaan GF; Lambrecht BN
    J Exp Med; 2008 Jul; 205(7):1621-34. PubMed ID: 18591406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC2 deficiency in cutaneous dendritic cells potentiates CD8
    Watson AR; Dai H; Diaz-Perez JA; Killeen ME; Mathers AR; Thomson AW
    Am J Transplant; 2019 Mar; 19(3):646-661. PubMed ID: 30129283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time.
    Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW
    J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages.
    Satoh E; Li XK; Hara Y; Ogata K; Guo L; Kitazawa Y; Funeshima-Fuji N; Satoh T; Miyagi T; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H
    Transpl Immunol; 2007 Nov; 18(2):73-84. PubMed ID: 18005848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients.
    Kwun J; Hu H; Schadde E; Roenneburg D; Sullivan KA; DeMartino J; Burlingham WJ; Knechtle SJ
    J Immunol; 2007 Dec; 179(12):8016-25. PubMed ID: 18056341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft.
    Kwun J; Farris AB; Song H; Mahle WT; Burlingham WJ; Knechtle SJ
    Transplantation; 2015 Dec; 99(12):2485-93. PubMed ID: 26102611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
    Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway".
    Sano Y; Streilein JW; Ksander BR
    Transplantation; 1999 Oct; 68(7):963-70. PubMed ID: 10532535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of allogeneic islet grafts in an experimental mouse model before rejection or tolerance phenotypes arise.
    Choi SE; Noh JR; Seo J; Yang KJ; Kook MC; Lee CH
    Transplant Proc; 2013 Mar; 45(2):597-604. PubMed ID: 23498796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.